RK
Ravi Kumar Pericherla
About Ravi Kumar Pericherla
Data last updated:
Ravi Kumar Pericherla is a Director at Genex Laboratories Private Limited (since 2008), Director at Genotech Pharmaceuticals Private Limited (since 2018) and Director at Genotech Health And Life Sciences Private Limited (since 2016). The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹1.29 Cr; the largest is Genex Laboratories Private Limited at ₹1.04 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Genex Laboratories Private Limited U24233TG2008PTC060481 | Director | 06 Aug 2008 | 2008 | ₹1.04 Cr (FY 2025) | Active |
 Genotech Pharmaceuticals Private Limited U24232TG2010PTC068845 | Director | 13 Jul 2018 | 2010 | ₹25.4 Lakh (FY 2025) | Active |
 Genotech Health And Life Sciences Private Limited U24304TG2016PTC110484 | Director | 23 Jun 2016 | 2016 | ₹13,987 (FY 2024) | Active |
Board colleagues of Ravi Kumar Pericherla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pericherla Aruna | 08939709 | Genex Laboratories Private Limited | Director |
| Murari Rajakumari | 09198855 | Genotech Pharmaceuticals Private Limited | Director |
| Suryanarayana Kolagani | 07518632 | Genotech Pharmaceuticals Private Limited , Genotech Health And Life Sciences Private Limited | Director |
| Thaduri Srivani | 02658723 | Genotech Pharmaceuticals Private Limited | Director |
| Lakamsani Hymavathi | 08855776 | Genotech Health And Life Sciences Private Limited | Director |
| Satya Ravindra Krishna Lakamsani | 08855775 | Genotech Health And Life Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Kumar Pericherla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Kumar Pericherla
Ravi Kumar Pericherla currently holds 3 directorships: Genex Laboratories Private Limited (Director, since 06 Aug 2008, revenue ₹1.04 Cr (FY 2025)); Genotech Pharmaceuticals Private Limited (Director, since 13 Jul 2018, revenue ₹25.4 Lakh (FY 2025)); Genotech Health And Life Sciences Private Limited (Director, since 23 Jun 2016, revenue ₹13,987 (FY 2024)).
Ravi Kumar Pericherla was first appointed on 06 Aug 2008 as Director at Genex Laboratories Private Limited. The most recent appointment on record is 13 Jul 2018 at Genotech Pharmaceuticals Private Limited.
The 3 current companies of Ravi Kumar Pericherla that report revenue have a combined latest revenue of ₹1.29 Cr: Genex Laboratories Private Limited ₹1.04 Cr (FY 2025); Genotech Pharmaceuticals Private Limited ₹25.4 Lakh (FY 2025); Genotech Health And Life Sciences Private Limited ₹13,987 (FY 2024).
The current boards of Ravi Kumar Pericherla's companies include Pericherla Aruna (Genex Laboratories Private Limited), Murari Rajakumari (Genotech Pharmaceuticals Private Limited), Suryanarayana Kolagani (Genotech Pharmaceuticals Private Limited), Thaduri Srivani (Genotech Pharmaceuticals Private Limited), Lakamsani Hymavathi (Genotech Health And Life Sciences Private Limited), Satya Ravindra Krishna Lakamsani (Genotech Health And Life Sciences Private Limited).